Esteve buys a drug for medullary thyroid cancer from Sanofi

Catalan pharmaceutical company Esteve has announced an agreement with Sanofi to acquire Caprelsa, a drug used in adults and children over 5 years of age to treat medullary thyroid cancer.

Esteve puts the spotlight on his purchasing strategy: "The thickness is yet to come."